LeMaitre Vascular Inc
General ticker "LMAT" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.3B
LeMaitre Vascular Inc follows the US Stock Market performance with the rate: 66.9%.
Estimated limits based on current volatility of 1.6%: low 89.88$, high 93.19$
Factors to consider:
- Company pays dividends: last record date 2024-11-21, amount 0.16$ (Y0.69%)
- US accounted for 60.9% of revenue in the fiscal year ended 2023-12-31
- Current price 18.2% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [54.60$, 77.95$]
- 2024-12-30 to 2025-12-30 estimated range: [59.97$, 84.69$]
Financial Metrics affecting the LMAT estimates:
- Positive: 0.93 < Non-GAAP EPS, $ of 1.34
- Positive: 9.05 < Operating profit margin, % of 18.97
- Positive: Inventory ratio change, % of -2.43 <= -1.03
- Positive: 2.35 < Operating cash flow per share per price, % of 3.03
- Positive: Return on assets ratio (scaled to [-100,100]) of 7.99 > 7.10
Short-term LMAT quotes
Long-term LMAT plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $154.42MM | $161.65MM | $193.48MM |
Operating Expenses | $118.00MM | $134.82MM | $156.77MM |
Operating Income | $36.42MM | $26.83MM | $36.71MM |
Non-Operating Income | $-2.14MM | $0.66MM | $2.76MM |
Interest Expense | $2.22MM | $0.99MM | $0.00MM |
R&D Expense | $11.80MM | $13.29MM | $16.97MM |
Income(Loss) | $34.29MM | $27.49MM | $39.48MM |
Taxes | $7.38MM | $6.85MM | $9.37MM |
Profit(Loss) | $26.91MM | $20.64MM | $30.11MM |
Stockholders Equity | $254.15MM | $268.20MM | $297.90MM |
Inventory | $46.10MM | $50.27MM | $52.33MM |
Assets | $292.80MM | $310.48MM | $346.78MM |
Operating Cash Flow | $35.10MM | $25.38MM | $36.75MM |
Capital expenditure | $4.88MM | $3.23MM | $7.26MM |
Investing Cash Flow | $-61.08MM | $-10.37MM | $-24.71MM |
Financing Cash Flow | $13.70MM | $-9.23MM | $-7.13MM |
Earnings Per Share* | $1.27 | $0.94 | $1.36 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.